Diminishing availability of publicly funded slots for antiretroviral initiation among HIV-infected ART-eligible patients in Uganda - sprookjes - yvandenbroek - TriplyDB

Diminishing availability of publicly funded slots for antiretroviral initiation among HIV-infected ART-eligible patients in Uganda

Diminishing availability of publicly funded slots for antiretroviral initiation among HIV-infected ART-eligible patients in Uganda

http://www.wikidata.org/entity/Q33760929

about

Convergence of mortality rates among patients on antiretroviral therapy in South Africa and North America Cost-effectiveness of early treatment with first-line NNRTI-based HAART regimens in the UK, 1996-2006 The dynamic relationship between social support and HIV-related stigma in rural Uganda.HIV-infected women on antiretroviral treatment have increased mortality during pregnant and postpartum periods Antiretroviral Therapy Helps HIV-Positive Women Navigate Social Expectations for and Clinical Recommendations against Childbearing in Uganda.HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda.Sexual relationship power and depression among HIV-infected women in Rural Uganda Depression during pregnancy and the postpartum among HIV-infected women on antiretroviral therapy in Uganda Declining prevalence of probable depression among patients presenting for antiretroviral therapy in rural Uganda: the role of early treatment initiation Incidence and predictors of pregnancy among a cohort of HIV-positive women initiating antiretroviral therapy in Mbarara, Uganda.Persistent HIV-related stigma in rural Uganda during a period of increasing HIV incidence despite treatment expansion The social context of food insecurity among persons living with HIV/AIDS in rural Uganda Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial.The clock is ticking: the rate and timeliness of antiretroviral therapy initiation from the time of treatment eligibility in Kenya.Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review.Food insecurity is associated with morbidity and patterns of healthcare utilization among HIV-infected individuals in a resource-poor setting.Evaluation of quantification of HIV-1 RNA viral load in plasma and dried blood spots by use of the semiautomated Cobas Amplicor assay and the fully automated Cobas Ampliprep/TaqMan assay, version 2.0, in Kisumu, Kenya.No association found between traditional healer use and delayed antiretroviral initiation in rural Uganda.HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods.How does antiretroviral treatment attenuate the stigma of HIV? Evidence from a cohort study in rural Uganda Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis.Changes in food insecurity, nutritional status, and physical health status after antiretroviral therapy initiation in rural Uganda.Where are we now? A multicountry qualitative study to explore access to pre-antiretroviral care services: a precursor to antiretroviral therapy initiation.Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study.From a global crisis to the 'end of AIDS': New epidemics of signification.HIV Infection and risk of postpartum infection, complications and mortality in rural Uganda.Predicting short-term interruptions of antiretroviral therapy from summary adherence data: Development and test of a probability model.Prevalence and correlates of physical and sexual intimate partner violence among women living with HIV in Uganda

P2860

Q21034185-8AA54613-5354-40E8-80C0-AA5DAF29FF11 Q28744286-78BC67A3-0CDD-4C9D-9395-9ABB653EACE7 Q33923013-99880C02-F87A-43C9-AC7E-2235E41A2273 Q34081657-93135700-B83B-445D-BD04-6618B9A2E56E Q34307108-1B66B8C2-B493-42A0-94D5-200E03313F79 Q34339517-3D3E2026-4DEF-4379-AB7E-42F0CF3E16D0 Q34401635-084ACBBC-2C65-4AB6-BB41-65BEB4B91B8D Q34539991-C8F2BD19-A3CB-4B5C-8928-6C6CAD5AFFE4 Q34611305-C840459F-B528-4957-8302-EF63D320ECEA Q34633232-0FEF39CA-E471-42F1-9B75-644F2A1A0B1A Q34737416-7C5802E5-DB28-4902-B671-67251E9CA93A Q34860499-1D058137-CD4D-4FBE-93B5-21480A3FAFA7 Q35566405-6DEFDFCD-04EA-46CD-A75A-7CA0732D4483 Q36167250-5A10A8A8-E9AD-440E-AD76-2FD65BE9B7CD Q36215535-BE8BC474-FEA1-42F3-947B-369AD47D5582 Q36414972-7256C0DB-8E2B-4CDB-BDD5-35DD0B5C8FA4 Q36712382-181FE78C-B132-449C-9ED1-F1A988168219 Q36884491-69B9E3A2-985D-4FC0-9DA3-C244786CE99F Q37033975-3A0DF186-C526-4FCD-892B-FB1420F3C347 Q37092383-7F8B31B9-8AC6-4E09-BF44-4C0177656222 Q37171423-867631C0-01D7-4B4E-951C-356C90B8E249 Q37493007-19B14622-9D20-4E37-878B-0597D77C89C3 Q37627711-4A154AC8-6A48-42F5-A60D-02FF8389F2FC Q38849967-084ED25C-1F7D-4883-9961-71B82681037F Q38868438-D08EE752-C474-4CE8-AF5E-079A5EF24CC5 Q42004168-019FE1A0-EFEA-4404-B104-DA4CE252B40F Q49943871-38C781E8-EFD4-4D39-9177-C8134FD61F87 Q52642676-22ED7721-90A0-4FF9-A026-76D23D28CCD6 Q56910133-1DC753A9-3FAB-4CBD-8338-A988592730A0

P2860

Diminishing availability of publicly funded slots for antiretroviral initiation among HIV-infected ART-eligible patients in Uganda

http://www.wikidata.org/entity/Q33760929

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Diminishing availability of pu ...... RT-eligible patients in Uganda

@ast

Diminishing availability of pu ...... RT-eligible patients in Uganda

@en

type

label

Diminishing availability of pu ...... RT-eligible patients in Uganda

@ast

Diminishing availability of pu ...... RT-eligible patients in Uganda

@en

prefLabel

Diminishing availability of pu ...... RT-eligible patients in Uganda

@ast

Diminishing availability of pu ...... RT-eligible patients in Uganda

@en

P1433

Q33760929-4D602117-30DE-428D-A01E-343BBD988127

P1476

Q33760929-E7F75D3E-8AFE-4D50-8006-F1D83920A244

P2093

Q33760929-318F39B8-767D-4BBC-9D6E-BB87D54BA90A

Q33760929-3C2E4B9F-0FA9-409A-A340-0698720721DE

Q33760929-9AFC856E-BF5D-4627-9EC5-2F0E242B019E

Q33760929-AB15518E-C3B1-49EA-9E4B-667D952C70EA

Q33760929-AC2B68C9-A75E-4F04-96B2-145334421CB9

Q33760929-C86991D6-10AF-4FA8-960A-4DFE028B49A0

Q33760929-E995DDAE-373D-4CC9-B618-AF12955F1157

P2860

Q33760929-35E0F698-397F-4D21-8905-D7A42A256164

Q33760929-7979EDF1-1F77-4DD1-A41B-F4086BF74F6E

Q33760929-7FBDBD39-E4FE-4250-8BE0-9D0DFDC86B64

Q33760929-84248CD7-877E-4325-86C8-8D216AF36195

Q33760929-93141C16-CAB6-481D-A8CA-5FC234EFAA15

Q33760929-A5127577-A80A-47DA-8921-AAE586505289

Q33760929-B33D677B-AD8B-43DE-962D-9814039E153C

Q33760929-B4BC9396-0351-4A7D-A427-58853158BD63

Q33760929-FD950B7E-4ECC-4816-8202-C11FE07E29F5

P304

Q33760929-275A775A-97EC-4EF7-99BB-41739329A0CA

P31

Q33760929-190DFF18-AFD6-49AA-8529-D95DDE65FBAB

P356

Q33760929-CD20632E-805A-441E-A916-EE402FB6AF80

P407

Q33760929-50014517-6700-4AD8-8D56-57D208BD73C1

P433

Q33760929-8E1B4F10-3BDF-4C99-8A9F-43D9AE8A2FFD

P478

Q33760929-3BE0F67D-087D-4412-9E6A-089D660DF044

P50

Q33760929-8E1EAC30-0B95-4EDE-820D-97C37BCE65A1

Q33760929-BBFA6F4B-5ABA-41B0-AE19-0B14C7F9A194

P577

Q33760929-A1257892-61C5-46D5-964F-CE551C4EA2D8

P5875

Q33760929-C5A961A4-042E-436B-B87D-330B92B2F53B

P698

Q33760929-582064A6-DD94-4EC8-901D-09F0BFDBC198

P921

Q33760929-8BC2477C-6231-4126-B0F9-8CB0E36B9354

Q33760929-DEA845D8-5889-4F6D-A762-D55F60D1A8FF

P932

Q33760929-C5578950-60EE-48C9-B21D-38A2BBC98B99

P356

JOURNAL.PONE.0014098

P1433

P1476

Diminishing availability of pu ...... RT-eligible patients in Uganda

@en

P2093

Elvin H Geng

http://www.w3.org/2001/XMLSchema#string

Jeffrey N Martin

http://www.w3.org/2001/XMLSchema#string

Jerome Kabakyenga

http://www.w3.org/2001/XMLSchema#string

Nicholas Musinguzi

http://www.w3.org/2001/XMLSchema#string

Nneka I Emenyonu

http://www.w3.org/2001/XMLSchema#string

Peter Mugyenyi

http://www.w3.org/2001/XMLSchema#string

Winnie Muyindike

http://www.w3.org/2001/XMLSchema#string

P2860

Explaining adherence success in sub-Saharan Africa: an ethnographic study

Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review

Mortality reduction associated with HIV/AIDS care and antiretroviral treatment in rural Malawi: evidence from registers, coffin sales and funerals

The Economic Impact of AIDS Treatment: Labor Supply in Western Kenya.

Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.

Adherence as therapeutic citizenship: impact of the history of access to antiretroviral drugs on adherence to treatment.

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.

Bridging the resource gap: improving value for money in HIV/AIDS treatment.

The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings.

P304

e14098

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0014098

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

David R Bangsberg

Mwebesa Bosco Bwana

P577

2010-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49651905

http://www.w3.org/2001/XMLSchema#string

P698

21124842

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

2991339

http://www.w3.org/2001/XMLSchema#string